Protection from viral infections by human milk oligosaccharides: Direct blockade and indirect modulation of intestinal ecology and immune reactions

Open Glycoscience

Volumn 5, Issue 1, 2012, Pages 19-25

  Yang, Betsy ^a   Chuang, Hau ^b   Chen, Rong Fu ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Fucosyltransferase; Galactose; Glycan; Glycosyltransferase; Human milk oligosaccharides (HMOs); Lactose; Lectin; Lewis X; Sialic acid; Viral infection

Indexed keywords

AVIAN INFLUENZA VIRUS; CYTOMEGALOVIRUS; HEPATITIS C VIRUS; HUMAN ENTEROVIRUS 71; NOROVIRUS;

EID: 84861898695     PISSN: None     EISSN: 18753981     Source Type: Journal    
DOI: 10.2174/1875398101205010019     Document Type: Review

References (55)

1. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011; 30: 16-34.
2. Rogers KM, Heise M. Modulation of cellular tropism and innate antiviral response by viral glycans. J Innate Immun 2009; 1: 405-12.
3. Geijtenbeek TB, van Kooyk Y. Pathogens target DC-SIGN to influence their fate DC-SIGN functions as a pathogen receptor with broad specificity. APMIS 2003; 111: 698-714.
4. Gardner JP, Durso RJ, Arrigale RR et al. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc Natl Acad Sci USA 2003; 100: 4498-503.
5. Powlesland AS, Fisch T, Taylor ME, Smith DF, Tissot B, Dell A. Pöhlmann S, Drickamer K. A novel mechanism for LSECtin bind-ing to Ebola virus surface glycoprotein through truncated glycans. J Biol Chem 2008; 2831: 593-602.
6. Wang L, Chen RF, Liu JW, et al. DC-SIGN (CD209) Promoter -336 A/G polymorphism is associated with dengue hemorrhagic fe-ver and correlated to DC-SIGN expression and immune augmentation. PLoS Negl Trop Dis 2011; 5:e934.
7. Suzuki Y. The highly pathogenic avian influenza H5N1-initial molecular signals for the next influenza pandemic. Chang Gung Med J 2009; 32: 258-63.
8. Nilsson EC, Jamshidi F, Johansson SM, Oberste MS, Arnberg N. Sialic acid is a cellular receptor for coxsackievirus A24 variant, an emerging virus with pandemic potential. J Virol 2008; 82: 3061-8.
9. Yang B, Chuang H, Yang KD. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J 2009; 6: 141.
10. Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 2009; 15: 794-7.
11. Jiang X, Huang P, Zhong W, et al. Human milk contains elements that block binding of noroviruses to human histo-blood group antigens in saliva. J Infect Dis 2004; 190: 1850-9.
12. Morrow AL, Ruiz-Palacios GM, Altaye M, et al. Human milk oligosaccharides are associated with protection against diarrhea in breastfed infants. J Pediatr 2004; 145:297-303.
13. Sazawal S, Dhingra U, Hiremath G, et al. Prebiotic and probiotic fortified milk in prevention of morbidities among children: communitybased, randomized, double-blind, controlled trial. PLoS One 2010; 5: e12164.
14. Rockova S, Rada V, Marsik P, et al. Growth of bifidobacteria and clostridia on human and cow milk saccharides. Anaerobe 2011; 17: 223-5.
15. Newburg DS. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci 2009; 87(13 Suppl): 26-34.
16. Urashima T, Kitaoka M, Asakuma S, Messer M. Milk oligosaccharides. Adv Dairy Chem 2009; 3: 295-349.
17. German JB, Freeman SL, Lebrilla CB, Mills DA. Human milk oligosaccharides: evolution, structures and bioselectivity as substrates for intestinal bacteria. Nestle Nutr Workshop Ser Pediatr Program 2008; 62: 205-18.
18. LoCascio RG, Ninonuevo MR, Freeman SL, et al. Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. J Agric Food Chem 2007; 55: 8914-9.
19. Sela DA, Mills DA. Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides. Trends Micro-biol 2010; 18: 298-307.
20. Bode L. Recent advances on structure, metabolism, and function of human milk oligosaccharides. J Nutr 2006; 136: 2127-30.
21. Bode L. Human milk oligosaccharides: prebiotics and beyond. Nutr Rev 2009; 67: S183-S191.
22. de Kivit S, Kraneveld AD, Garssen J, Willemsen LE. Glycan rec-ognition at the interface of the intestinal immune system: Target for immune modulation via dietary components. Eur J Pharmacol 2011; 668 (Suppl. 1): S124-32.
23. Sela DA. Bifidobacterial utilization of human milk oligosaccha-rides. Int J Food Microbiol 2011; 149: 58-64.
24. Wang B, Brand-Miller J, McVeagh P, Petocz P. Concentration and distribution of sialic acid in human milk and infant formulas. Am J Clin Nutr 2001;74: 510-15.
25. Oriol R, Le Pendu J, Mollicone R. Genetics of ABO, H, Lewis, X and related antigens. Vox Sang 1986; 51: 161-71.
26. Lewis antigen system. Retrieved from Wikipedia, the free encyclopedia http://en.wikipedia.org/wiki/Lewis_antigen_system
27. Asakuma S, Urashima T, Akahori M, et al. Variation of major neutral oligosaccharides levels in human colostrum. Eur J Clin Nutr 2008; 62: 488-94.
28. Huffman SL, Zehner ER, Victora C. Can improvements in breast-feeding practices reduce neonatal mortality in developing coun-tries? Midwifery 2001; 17: 80-92.
29. Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr 2005; 135:1304-7.
30. Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, Newburg DS. Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem 2003; 278: 14112-20.
31. Hutson AM, Atmar RL, Graham DY, Estes MK. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 2002;185: 1335-7.
32. Le Pendu J. Histo-blood group antigen and human milk oligosac-charides: genetic polymorphism and risk of infectious diseases. Adv Exp Med Biol 2004; 554: 135-43.
33. Carbohydrates In Food Chemistry, Hans-Dieter Belitz,Werner Grosch, Peter Schieberle. 3rd ed, Springer-Verlag Berlin Heidelburg, 2004; pp. 245-341.
34. Foda MI, Kholif SM, Kholif AM. Evaluation of goat milk contain-ing galactooligosaccharides after supplementing the ration with amino acids. Intl J Dairy Sci 2009; 4: 27-33.
35. Newburg DS, Ruiz-Palacios GM, Morrow AL. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 2005; 25: 37-58.
36. Stahl BS, Thurl S, Henker TJ, Siegel M, Finke B, Sawatzki G. Detection of four human milk groups with respect to Lewis-blood-group-dependent oligosaccharides by serologic and chromatographic analysis. Adv Exp Med Biol 2001; 501: 299-306.
37. Nordén R, Nyström K, Olofsson S. Activation of host antiviral RNA-sensing factors necessary for herpes simplex virus type 1-activated transcription of host cell fucosyltransferase genes FUT3, FUT5, and FUT6 and subsequent expression of sLe(x) in virus-infected cells. Glycobiology 2009; 19: 776-88.
38. Kitazume S, Oka R, Ogawa K, et al. Molecular insights into beta-galactoside alpha2,6-sialyltransferase secretion in vivo. Glycobiol-ogy 2009; 19: 479-87.
39. Orntoft TF, Vestergaard EM, Holmes E, et al. Influence of Lewis alpha1-3/4-L-fucosyltransferase (FUT3) gene mutations on enzyme activity, erythrocyte phenotyping, and circulating tumor marker sialyl-Lewis a levels. J Biol Chem 1996; 271: 32260-8.
40. Naarding MA, Ludwig IS, Groot F, et al. Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes. J Clin Invest 2005; 115: 3256-64.
41. Gambaryan AS, Tuzikov AB, Pazynina GV, et al. 6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry. Virol J 2008; 5: 85.
42. Asakuma S, Akahori M, Kimura K, et al. Sialyl oligosaccharides of human colostrum: changes in concentration during the first three days of lactation. Biosci Biotechnol Biochem 2007; 71: 1447-51.
43. Heinig MJ, Dewey KG. Health advantages of breast feeding for infants: a critical review. Nutr Res Rev 1996; 9: 89-110.
44. Wang B. Sialic acid is an essential nutrient for brain development and cognition. Annu Rev Nutr 2009; 29: 177-222.
45. Takeda T, Sakata M, Minekawa R, et al. Human milk induces fetal small intestinal cell proliferation-involvement of a different tyro-sine kinase signaling pathway from epidermal growth factor recep-tor. J Endocrinol 2004; 181: 449-57.
46. Kuntzl S, Rudloff S, Kunz C. Oligosaccharides from human milk influence growth-related characteristics of intestinally transformed and non-transformed intestinal cells. Br J Nutr 2008; 99: 462-71.
47. Elbim C, Hakim J, Gougerot-Pocidalo MA. Heterogeneity in Lewis-X and sialyl-Lewis-X antigen expression on monocytes in whole blood: relation to stimulus-induced oxidative burst. Am J Pathol 1998; 152: 1081-90.
48. Bode L, Rudloff S, Kunz C, Strobel S, Klein N. Human milk oligo-saccharides reduce platelet-neutrophil complex formation leading to a decrease in neutrophil beta 2 integrin expression. J Leukoc Biol 2004; 76: 820-6.
49. Bode L, Kunz C, Muhly-Reinholz M, Mayer K, Seeger W, Rudloff S. Inhibition of monocyte, lymphocyte, and neutrophil adhesion to endothelial cells by human milk oligosaccharides. Thromb Haemost 2004; 92: 1402-10.
50. Liu FT. Regulatory roles of galectins in the immune response. Int Arch Allergy Immunol 2005; 136: 385-400.
51. Ideo H, Seko A, Ohkura T, Matta KL, Yamashita K. High-affinity binding of recombinant human galectin-4 to SO3-→3Galβ1→3GalNAc pyranoside. Glycobiology 2002; 12: 199-208.
52. Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol 2007; 7: 255-66.
53. Hara K, Ikeda M, Saito S, et al. Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes. Hepatol Res 2002; 24:228-35.
54. Harmsen MC, Swart PJ, de Béthune MP, et al. Antiviral effects of plasma and milk proteins: lactoferrin shows a potent activity against both human immunodeficiency virus and human cytomega-lovirus replication in vitro. J Infect Dis 1995; 172: 380-8.
55. Yolken RH, Peterson JA, Vonderfecht SL, Fouts ET, Midthun K, Newburg DS. Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J Clin Invest 1992; 90: 1984-91.